title: Relative adrenal insufficiency as a predictor of disease severity and mortality in severe septic shock.
abstract: OBJECTIVE
  To evaluate if cortisol responses to 250 µg of intravenously administered adrenocorticotropic hormone are related to disease severity and, hence, mortality.
  
  
  METHODS
  This is a retrospective study in a medical-surgical intensive care unit of a university hospital. We studied 69 consecutive patients with septic shock over a 1-yr period; these patients underwent a short 250-µg adrenocorticotropic hormone test because they exhibited >6 hours of progressive hemodynamic instability requiring repeated fluid challenges and vasopressor treatment to maintain blood pressure. The test was performed by intravenously injecting 250 µg of synthetic adrenocorticotropic hormone and measuring cortisol immediately before injection, 30 minutes post-injection and 60 minutes post-injection.
  
  
  RESULTS
  The mean APACHE II score was 22±7. The intensive care unit mortality rate at day 28 was 55%. Median baseline cortisol levels (19 [11-27] µg/dL versus 24 [18-34] µg/dL, p=0.047) and median baseline cortisol/albumin ratios (7.6 [4.6-12.3] versus 13.9 [8.8-18.5]; p=0.01) were lower in survivors than in non-survivors. Responders and non-responders had similar baseline clinical data and outcomes. The variables that were significantly correlated with outcome based on the area under the ROC curves (AUC) were APACHE II (AUC=0.67 [0.535 to 0.781]), baseline cortisol (µg/dl) (AUC=0.662 [0.536 to 0.773], peak cortisol (µg/dl) (AUC=0.642 [0.515 to 0.755]) and baseline cortisol/albumin (AUC=0.75 [0.621 to 0.849]).
  
  
  CONCLUSIONS
  Increased basal cortisol is associated with mortality and disease severity. Cortisol responses upon adrenocorticotropic hormone stimulation were not related to outcome. The cortisol/albumin ratio does not predict unfavorable outcomes better than total cortisol levels or help to improve the accuracy of the adrenocorticotropic hormone test.
authors.affiliation: Central Intensive Care Unit, ComplexoHospitalar Santa Casa - Porto Alegre (RS), Brazil.
authors.forename: Daniele
authors.initials: D
authors.lastname: Dalegrave
authors.forename: Rafael Lockshin
authors.initials: RL
authors.lastname: Silva
authors.forename: Maicon
authors.initials: M
authors.lastname: Becker
authors.forename: Lísia Varella
authors.initials: LV
authors.lastname: Gehrke
authors.forename: Gilberto
authors.initials: G
authors.lastname: Friedman
references.citation: N Engl J Med. 2003 Feb 20;348(8):727-34
references.pmid: 12594318
references.citation: Rev Bras Ter Intensiva. 2008 Mar;20(1):18-23
references.pmid: 25306943
references.citation: Crit Care Med. 2009 Jan;37(1):385-6; author reply 386-7
references.pmid: 19112330
references.citation: Anesth Analg. 2008 Jun;106(6):1813-9
references.pmid: 18499615
references.citation: Crit Care Med. 2007 Aug;35(8):1896-903
references.pmid: 17568326
references.citation: Shock. 2003 Jan;19(1):13-5
references.pmid: 12558137
references.citation: JAMA. 2002 Aug 21;288(7):862-71
references.pmid: 12186604
references.citation: Intensive Care Med. 1996 Sep;22(9):894-9
references.pmid: 8905423
references.citation: Crit Care. 2004 Aug;8(4):R251-60
references.pmid: 15312226
references.citation: J Clin Endocrinol Metab. 2003 May;88(5):2045-8
references.pmid: 12727952
references.citation: Intensive Care Med. 2005 Oct;31(10):1362-9
references.pmid: 16151722
references.citation: Crit Care Med. 2008 Jun;36(6):1937-49
references.pmid: 18496365
references.citation: Rev Bras Ter Intensiva. 2006 Mar;18(1):9-17
references.pmid: 25310321
references.citation: N Engl J Med. 2004 Apr 15;350(16):1629-38
references.pmid: 15084695
references.citation: Rev Bras Ter Intensiva. 2006 Mar;18(1):86-94
references.pmid: 25310332
references.citation: Support Care Cancer. 2012 Jun;20(6):1159-67
references.pmid: 21604086
references.citation: Clin Endocrinol (Oxf). 2004 Jan;60(1):29-35
references.pmid: 14678284
references.citation: N Engl J Med. 2008 Jan 10;358(2):111-24
references.pmid: 18184957
references.citation: Arq Bras Endocrinol Metabol. 2011 Jun;55(5):295-302
references.pmid: 21881811
references.citation: JAMA. 2000 Feb 23;283(8):1038-45
references.pmid: 10697064
references.citation: Am J Respir Crit Care Med. 2006 Dec 15;174(12):1319-26
references.pmid: 16973979
references.citation: Intensive Care Med. 2000 Dec;26(12):1747-55
references.pmid: 11271081
references.citation: Crit Care Med. 1985 Oct;13(10):818-29
references.pmid: 3928249
references.citation: Intensive Care Med. 2006 Feb;32(2):275-280
references.pmid: 16432671
references.citation: Chest. 1992 Jun;101(6):1644-55
references.pmid: 1303622
references.citation: Intensive Care Med. 1994 Aug;20(7):489-95
references.pmid: 7995865
references.citation: Lancet. 1991 Mar 9;337(8741):582-3
references.pmid: 1671944
references.citation: Intensive Care Med. 2001 Oct;27(10):1584-91
references.pmid: 11685298
references.citation: Crit Care Med. 2008 Jan;36(1):296-327
references.pmid: 18158437
references.citation: Crit Care Med. 2003 Jan;31(1):141-5
references.pmid: 12545007
references.citation: Crit Care Med. 2005 Nov;33(11):2479-86
references.pmid: 16276169
references.citation: Horm Metab Res. 2012 Apr;44(4):296-301
references.pmid: 22351474
references.citation: Chest. 1987 Aug;92(2):292-5
references.pmid: 3038477
references.citation: Crit Care Med. 2003 Jun;31(6):1668-75
references.pmid: 12794402
references.citation: Chest. 2009 Jan;135(1):181-193
references.pmid: 19136406
references.citation: Arch Surg. 2005 Jul;140(7):661-8; discussion 669
references.pmid: 16027331
references.citation: Chest. 2002 Nov;122(5):1784-96
references.pmid: 12426284